Canadian Cannabis LPs Draw More from Nova Scotia than British Columbia or Quebec

Health Canada released monthly data today on its medical cannabis program. Until this release, all of the data had been quarterly. At the end of June, there were 201,398 active clients, representing 168% growth from a year ago and 20% growth from the prior quarter. While this is very strong growth, it reflects a slowdown from the 29% growth in the prior quarter ending in March and the 32% growth in the quarter ending in December. The 20% sequential quarterly growth was the lowest since March 2015.

Source: Health Canada

For the first time, Health Canada reported data by province of residence, including client registrations with LPs or for personal or designated production (6880, including 6374 personal producers and 506 designated growers). Health Canada also reported 2786 health care practitioners who provided a medical document to a patient during June.

The data revealed that the LPs have done very well in Alberta and Ontario but have not achieved much penetration into British Columbia or Quebec. In total, 79.6% of all LP patients at the end of June resided in Alberta or Ontario, which together represent 50% of the Canadian population, while just 6.8% lived in BC or Quebec, which together represent 36% of the Canadian population. Several smaller provinces make up the bulk of the remainder.

Source: Health Canada

It’s not surprising that BC shuns the LPs given the abundance of dispensaries that operate in the grey and black markets. The low penetration in Quebec may be due to the requirement that all patients must join a registry. 32 of the 58 licenses issued to date are for facilities in Ontario, while only 1 has been issued in Quebec.

The data also showed continued strong demand for oils relative to flower. During the quarter, LPs shipped 5.896mm grams of dried flower, representing growth of just 1% from the prior quarter and 46% from a year ago. Oil sales, expressed in weight, were 6.194mm grams, up 9% from the prior quarter and 313% from a year ago.

Exclusive article by Alan Brochstein, CFA

ab-byline-ncvBased in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV.

Contact Alan: Twitter | Facebook | LinkedIn | Email

Latest News
Get The App

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.


ncv-news-ios-app-store

ncv-news-google-play

NCV Media

Thank you for reading

New Cannabis Ventures

Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors.

FOLLOW US ON